These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27569685)

  • 21. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperandrogenism Decreases GRP78 Protein Level and Glucose Uptake in Human Endometrial Stromal Cells.
    Rosas C; Oróstica L; Poblete C; Carvajal R; Gabler F; Romero C; Lavandero S; Vega M
    Reprod Sci; 2016 Jun; 23(6):761-70. PubMed ID: 26614265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
    Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
    Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bushen Huoxue Recipe inhibits endometrial epithelial-mesenchymal transition through the transforming growth factor-β/nuclear factor kappa-B pathway to improve polycystic ovary syndrome-mediated infertility.
    Wu H; Wu P; Zhu Y; Li J; Chen H; Zhu H
    Gynecol Endocrinol; 2024 Dec; 40(1):2325000. PubMed ID: 38477938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Endometrial Transcriptome of Metabolic and Inflammatory Pathways During the Window of Implantation Is Deranged in Infertile Obese Polycystic Ovarian Syndrome Women.
    Salamun V; Rizzo M; Lovrecic L; Hocevar K; Papler Burnik T; Janez A; Jensterle M; Vrtacnik Bokal E; Peterlin B; Maver A
    Metab Syndr Relat Disord; 2022 Sep; 20(7):384-394. PubMed ID: 35834645
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
    González F; Minium J; Rote NS; Kirwan JP
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
    Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
    Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of androst-5-ene-3β,17β-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome.
    Plaza-Parrochia F; Bacallao K; Poblete C; Gabler F; Carvajal R; Romero C; Valladares L; Vega M
    Steroids; 2014 Nov; 89():11-9. PubMed ID: 25065586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
    Jakubowicz DJ; Nestler JE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):556-60. PubMed ID: 9024253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients.
    Paravati R; De Mello N; Onyido EK; Francis LW; Brüsehafer K; Younas K; Spencer-Harty S; Conlan RS; Gonzalez D; Margarit L
    J Mol Med (Berl); 2020 Dec; 98(12):1713-1725. PubMed ID: 33047155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
    Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
    Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.
    Buyalos RP; Geffner ME; Bersch N; Judd HL; Watanabe RM; Bergman RN; Golde DW
    Fertil Steril; 1992 Apr; 57(4):796-803. PubMed ID: 1555690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
    Mioni R; Chiarelli S; Xamin N; Zuliani L; Granzotto M; Mozzanega B; Maffei P; Martini C; Blandamura S; Sicolo N; Vettor R
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4089-96. PubMed ID: 15292352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.